The pharmaceutical, technology, and energy sectors have been abuzz with news this week. In the pharmaceutical sector, Bristol-Myers Squibb (NYSE:BMY) said it has agreed to acquire Zymogenetics (NASDAQ:ZGEN) for $9.
MarketNewsVideo.com, Forbes
Thu, 09/09/2010 - 3:11pm
The pharmaceutical, technology, and energy sectors have been abuzz with news this week. In the pharmaceutical sector, Bristol-Myers Squibb (NYSE:BMY) said it has agreed to acquire Zymogenetics (NASDAQ:ZGEN) for $9.